Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic중등도에서 중증의 아토피 피부염을 가진 청소년의 Dupilumab: COVID-19 전염병 동안 32주간의 실제 경험 Published on 2022-01-012022-09-12 Journal: Clinical and experimental dermatology [키워드] atopic COVID-19 pandemic Dupilumab moderate [저자] K Hansel, C Patruno, E Antonelli, G Dal Bello, M Napolitano, G Fabbrocini, T Grieco, G Pellacani, M C Fargnoli, M Esposito, V Piras, M Zucca, G Girolomoni, L Stingeni [Category] MERS, 진단, PMC URL [DOI] 10.1111/ced.14862 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 COVID-19 pandemic, moderate, Dupilumab, atopic,